Alaunos Therapeutics TCRT
NASDAQ TCRT
$1.65 +0.04 (+2.47%)
As of: Nov 12, 2026 · 12:36 PM EST

Alaunos Therapeutics (TCRT) Cost of Revenue (2009 - 2011)

Updated

Alaunos Therapeutics' Cost of Revenue was $10.67 million in Q3 2011, up 86.8% from $5.71 million a year earlier and up 16.9% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Cost of Revenue (2009 - 2011) Analysis & Trends

On a trailing twelve-month basis, Alaunos Therapeutics' Cost of Revenue was $27.73 million through Sep 30, 2011.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.29 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.03 Bn
10 Alaunos Therapeutics 4.16 Mn 357,198.54 - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 10.67 Mn
Jun 30, 2011 9.13 Mn
Sep 30, 2010 5.71 Mn
Jun 30, 2010 2.22 Mn
Sep 30, 2009 1.23 Mn
API Access

Alaunos Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TCRT&period=max&api_key=YOUR_API_KEY